Hunting for a cure: The therapeutic potential of gene therapy in Duchenne muscular dystrophy

被引：3

作者：

Hashim, Hasnur Zaman ^{[1
]}

Abdullah, Shahrin Tarmizi Che ^{[1
]}

Sulaiman, Wan Aliaa Wan ^{[2
]}

Hoo, Fan Kee ^{[2
]}

Basri, Hamidon ^{[2
]}

机构：

[1] Int Islamic Univ Malaysia, Dept Internal Med, Pahang, Malaysia

[2] Univ Putra Malaysia, Fac Med & Hlth Sci, Dept Med, Neurol Unit, Serdang 43400, Selangor, Malaysia

来源：

TZU CHI MEDICAL JOURNAL | 2014年 / 26卷 / 01期

关键词：

Cure; Duchenne; Gene therapy; Muscular dystrophy;

D O I：

10.1016/j.tcmj.2014.02.002

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Duchenne muscular dystrophy (DMD) is an incurable disease and the search for a cure is a challenging journey. However, with recent encouraging progress, we are seeing a light at the end of a long tunnel. This review focuses on several main strategies in gene therapy, including truncated dystrophin gene transfer via viral vectors, antisense mediated exon skipping to restore the reading frame, and readthrough of translation stop codons. An exon skipping agent, eteplirsen, and a termination codon read drug, ataluren, are currently the most promising therapies. With better understanding of the molecular mechanism, gene therapy has improved with regard to the key areas of gene stability, safety, and route of delivery. Consequently, it has emerged as an exciting and hopeful means for novel treatment of this devastating disease. Copyright (C) 2014, Buddhist Compassion Relief Tzu Chi Foundation. Published by Elsevier Taiwan LLC. All rights reserved.

引用

页码：5 / 9

页数：5

共 58 条

[41] Pharmacological prospects in the treatment of Duchenne muscular dystrophy [J].

Ruegg, Urs T. .

CURRENT OPINION IN NEUROLOGY, 2013, 26 (05) :577-584

[42] The dystrophin complex forms a mechanically strong link between the sarcolemma and costameric actin [J].

Rybakova, IN ;

Patel, JR ;

Ervasti, JM .

JOURNAL OF CELL BIOLOGY, 2000, 150 (05) :1209-1214

[43] Design of tissue-specific regulatory cassettes for high-level rAAV-mediated expression in skeletal and cardiac muscle [J].

Salva, Maja Z. ;

Himeda, Charis L. ;

Tai, Phillip W. L. ;

Nishiuchi, Eiko ;

Gregorevic, Paul ;

Allen, James M. ;

Finn, Eric E. ;

Nguyen, Quynh G. ;

Blankinship, Michael J. ;

Meuse, Leonard ;

Chamberlain, Jeffrey S. ;

Hauschka, Stephen D. .

MOLECULAR THERAPY, 2007, 15 (02) :320-329

[44] Do immune cells promote the pathology of dystrophin-deficient myopathies? [J].

Spencer, MJ ;

Tidball, JG .

NEUROMUSCULAR DISORDERS, 2001, 11 (6-7) :556-564

[45] INHIBITION OF ROUS-SARCOMA VIRAL-RNA TRANSLATION BY A SPECIFIC OLIGODEOXYRIBONUCLEOTIDE [J].

STEPHENSON, ML ;

ZAMECNIK, PC .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1978, 75 (01) :285-288

[46] Biodistribution and safety profile of recombinant adeno-associated virus serotype 6 vectors following intravenous delivery [J].

Stone, Daniel ;

Liu, Ying ;

Li, Zong-Yi ;

Strauss, Robert ;

Finn, Eric E. ;

Allen, James M. ;

Chamberlain, Jeffrey S. ;

Lieber, Andre .

JOURNAL OF VIROLOGY, 2008, 82 (15) :7711-7715

[47] Long-term Exon Skipping Studies With 2′-O-Methyl Phosphorothioate Antisense Oligonucleotides in Dystrophic Mouse Models [J].

Tanganyika-de Winter, Christa L. ;

Heemskerk, Hans ;

Karnaoukh, Tatyana G. ;

van Putten, Maaike ;

de Kimpe, Sjef J. ;

van Deutekom, Judith ;

Aartsma-Rus, Annemieke .

MOLECULAR THERAPY-NUCLEIC ACIDS, 2012, 1 :e44

[48] PRIMARY STRUCTURE OF DYSTROPHIN-RELATED PROTEIN [J].

TINSLEY, JM ;

BLAKE, DJ ;

ROCHE, A ;

FAIRBROTHER, U ;

RISS, J ;

BYTH, BC ;

KNIGHT, AE ;

KENDRICKJONES, J ;

SUTHERS, GK ;

LOVE, DR ;

EDWARDS, YH ;

DAVIES, KE .

NATURE, 1992, 360 (6404) :591-593

[49] LONG-TERM CORRECTION OF MOUSE DYSTROPHIC DEGENERATION BY ADENOVIRUS-MEDIATED TRANSFER OF A MINIDYSTROPHIN GENE [J].

VINCENT, N ;

RAGOT, T ;

GILGENKRANTZ, H ;

COUTON, D ;

CHAFEY, P ;

GREGOIRE, A ;

BRIAND, P ;

KAPLAN, JC ;

KAHN, A ;

PERRICAUDET, M .

NATURE GENETICS, 1993, 5 (02) :130-134

[50] Gentamicin treatment of Duchenne and Becker muscular dystrophy due to nonsense mutations [J].

Wagner, KR ;

Hamed, S ;

Hadley, DW ;

Gropman, AL ;

Burstein, AH ;

Escolar, DM ;

Hoffman, EP ;

Fischbeck, KH .

ANNALS OF NEUROLOGY, 2001, 49 (06) :706-711

← 1 2 3 4 5 6 →